uniQure Announces Results for First Quarter 2016
May 31, 2016 09:01 am UTC| Business
AMSTERDAM, the Netherlands, May 31, 2016 -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced financial results for the first quarter ending March 31, 2016, and provided a corporate...
Affimed to Present at the Jefferies 2016 Healthcare Conference
May 31, 2016 09:01 am UTC| Business
HEIDELBERG, Germany, May 31, 2016 -- Affimed N.V. (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi Hoess,...
Metso appoints Jani Puroranta as Chief Digital Officer
May 31, 2016 08:05 am UTC| Business
HELSINKI, Finland, May 31, 2016 -- Jani Puroranta has been appointed the Chief Digital Officer (CDO) of Metso starting August 1, 2016. The CDO will be responsible for driving the company's digital transformation and...
TowerJazz Announces Successful Completion of Non-Convertible Unsecured Bonds Institutional Tender
May 31, 2016 07:07 am UTC| Business
Received Binding Commitments of $100 Million from Israeli Institutional Investors for Long Term Non-Convertible Unsecured Bonds Maturing in 2023 Proceeds to Be Used For the Early Repayment of Its Outstanding $78 Million...
FRONTLINE LTD. REPORTS RESULTS FOR THE FIRST QUARTER 2016
May 31, 2016 06:58 am UTC| Business
HAMILTON, Bermuda, May 31, 2016 -- Frontline Ltd. (the "Company" or "Frontline"), today reported unaudited results for the three months ended March 31, 2016: Highlights Achieved net income attributable to the...
Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology
May 31, 2016 06:09 am UTC| Business
Small but heading for the big time Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology PARIS and CAMBRIDGE, Mass., May 31, 2016 --NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late...
Targovax to present at forthcoming conferences
May 31, 2016 06:05 am UTC| Business
OSLO, Norway, May 31, 2016 -- Targovax, a clinical stage immuno-oncology company, developing targeted immunotherapy treatments for cancer patients, announces that members of its senior management team will participate in...